CD24P2

Across TCGA pan-cancer cohorts, CD24P2 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated CD24P2 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher CD24P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CD24P2 expression acts as an unfavorable survival marker, although some lineages such as ESCA and UCS show a favorable association.

MESO, KICH, and ACC are the cancer types where CD24P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	All	0.216	0.425	.001	120	view →
KICH	DFS	Tertile	III,IV	0.256	0.910	<.001	114	view →
ACC	DFS	Tertile	All	0.039	0.778	<.001	60	view →
ESCA	DFS	Quartile	All	0.665	0.396	.001	28	view →
UVM	DFS	Tertile	All	0.079	0.746	<.001	27	view →
DLBC	DFS	Tertile	III,IV	0.070	0.855	.008	18	view →
UCS	OS	Tertile	IV	1.000	0.276	.018	18	view →
CESC	OS	Quartile	All	0.776	0.910	.005	18	view →
SKCM	DFS	Tertile	IV	0.016	0.541	.008	12	view →
READ	DFS	Tertile	IV	0.293	0.789	.002	12	view →
BRCA	OS	Quartile	All	0.486	0.628	.009	10	view →
SARC	DFS	Tertile	All	0.200	0.376	.028	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

CD24P2–MESO (OS)

Open the MESO breakdown →